A generic drug maker has launched its version of an Abbott Labs drug.
Watson has launched an authorized generic drug for treating postmenopausal women, the company said Friday.
The Food and Drug Administration turned down an application for a topical reproductive drug made by Watson Pharmaceuticals and Columbia Labs, the two companies said Monday.
A panel of experts at the Food and Drug Administration has declined to recommend approval for a topical drug for preventing premature birth in pregnant women, the drug's manufacturers said.
The Food and Drug Administration has accepted a regulatory approval application for a drug designed to prevent premature birth in pregnant women.
A drug designed to reduce the risk of premature birth among pregnant women has been submitted to the Food and Drug Administration for approval.
The New Life Agency has added a prescription progesterone supplement and RESOLVE: the National Fertility Association to the Fertility Pharmacy Care Card.
The Food and Drug Administration has approved a drug for preventing preterm births.
An investigational drug made by Watson Pharmaceuticals and Columbia Labs reduced the risk of premature birth, according to results of late-stage clinical trial.
Watson Pharmaceuticals will buy the U.S. rights to two progesterone products used to treat infertility...